Search
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
home
home
Roche
Roche
Page 3 of 4
Newsletters
The FDA Went on an Epic Drug Approval Binge This Week: Brainstorm Health
By
Sy Mukherjee
August 16, 2019
Health
Roche Bids $4.8 Billion for U.S.-Based Gene Therapy Specialist Spark
By
Tim Loh
,
Naomi Kresge
and
Bloomberg
February 25, 2019
Health
The FDA Approved the First Big New Flu Drug in Almost 20 Years—And Is Approaching a Drug Approval Record
By
Sy Mukherjee
October 24, 2018
Health
How to Innovate at Flatiron Health? It Starts With a Hackathon
By
Andrew Nusca
July 31, 2018
Health
Japan Just Approved a New Drug That Can Kill the Flu Virus In Just One Day
By
Sy Mukherjee
February 23, 2018
Health
Why Drug Giant Roche’s $1.9 Billion Deal to Buy Data Startup Flatiron Health Matters
By
Sy Mukherjee
February 16, 2018
Finance
Roche to Buy U.S. Cancer Drugmaker Ignyta for $1.7 Billion
By
Bloomberg
December 22, 2017
Health
A ‘Groundbreaking’ New Drug Shows Promise Against Huntington’s—But There’s a Catch
By
Sy Mukherjee
December 11, 2017
Health
Amgen Is Taking On a $3 Billion Cancer Drug. But Will It Cut Costs for Patients?
By
Sy Mukherjee
September 15, 2017
Health
Roche Loses Billions in Value After Pricey Breast Cancer Drug Combo Disappoints
By
Sy Mukherjee
June 5, 2017
Health
The FDA Just Approved the First Ever Drug to Treat Severe MS
By
Sy Mukherjee
March 29, 2017
Leadership
This Big Pharma CEO Thinks Trump’s Drug Pricing Threats Are All Bark and No Bite
By
Sy Mukherjee
February 2, 2017
Health
The FDA Has Issued Emergency Authorization for Roche’s Zika Test
By
Reuters
and
Michelle Toh
August 29, 2016
Health
Here’s Why HPV-Related Cancers Are Rising Among American Men
By
Sy Mukherjee
July 8, 2016
Health
These Are the Most Promising Experimental Cancer Drugs
By
Sy Mukherjee
June 9, 2016
Most Popular
Economy
The $38 trillion national debt is to blame for over $1 trillion in annual interest payments from here on out, CRFB says
By
Nick Lichtenberg
AI
Meta’s 28-year-old billionaire prodigy says the next Bill Gates will be a 13-year-old who is ‘vibe coding’ right now
By
Eva Roytburg
Success
As graduates face a ‘jobpocalypse,’ Goldman Sachs exec tells Gen Z they need to know their commercial impact
By
Preston Fore